Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
64
NCT07129694
Obtain Safety and Effectiveness of CT-ACL001, a Regenerative Ligament Using Biological Tissue, in ACLR
Phase: N/A
Role: Lead Sponsor
Start: Nov 25, 2024
Completion: Nov 30, 2027